200 related articles for article (PubMed ID: 25307224)
1. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.
Fan X; Jiang Y; Yu Z; Yuan J; Sun X; Xiang S; Lo EH; Wang X
Adv Pharmacol; 2014; 71():391-410. PubMed ID: 25307224
[TBL] [Abstract][Full Text] [Related]
2. Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy.
Jiang Y; Liu N; Han J; Li Y; Spencer P; Vodovoz SJ; Ning MM; Bix G; Katakam PVG; Dumont AS; Wang X
Transl Stroke Res; 2021 Jun; 12(3):416-427. PubMed ID: 33140258
[TBL] [Abstract][Full Text] [Related]
3. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
Wang W; Li M; Chen Q; Wang J
Mol Neurobiol; 2015 Dec; 52(3):1572-1579. PubMed ID: 25367883
[TBL] [Abstract][Full Text] [Related]
6. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
7. Hemorrhagic complications of thrombolytic therapy.
Vujković Z; Racić D; Miljković S; Dajić V
Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232
[TBL] [Abstract][Full Text] [Related]
8. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
9. Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy.
Wang X; Rosell A; Lo EH
CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):235-42. PubMed ID: 18673208
[TBL] [Abstract][Full Text] [Related]
10. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
[TBL] [Abstract][Full Text] [Related]
11. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.
Hafez S; Coucha M; Bruno A; Fagan SC; Ergul A
Transl Stroke Res; 2014 Aug; 5(4):442-453. PubMed ID: 24619488
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
14. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
Wang X; Tsuji K; Lee SR; Ning M; Furie KL; Buchan AM; Lo EH
Stroke; 2004 Nov; 35(11 Suppl 1):2726-30. PubMed ID: 15459442
[TBL] [Abstract][Full Text] [Related]
16. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
17. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production.
Won SJ; Tang XN; Suh SW; Yenari MA; Swanson RA
Ann Neurol; 2011 Oct; 70(4):583-90. PubMed ID: 22002675
[TBL] [Abstract][Full Text] [Related]
19. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
[TBL] [Abstract][Full Text] [Related]
20. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]